Citadel Advisors’s EnteroMedics Inc. ETRM Stock Holding History

Citadel Advisors’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2	Closed	-$1K	–	9760
2015 Q2	$1K	Buy	+2	New	+$2.3K	﹤0.01%	8684
2014 Q4	–	Sell	-5	Closed	-$6K	–	9153
2014 Q3	$6K	Hold	5	–	–	﹤0.01%	7902
2014 Q2	$8K	Sell	5 -2	-29%	-$3.74K	﹤0.01%	7655
2014 Q1	$14K	Buy	+7	New	+$16.6K	﹤0.01%	7422

Other funds holding ETRM

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Citadel Advisors's ETRM Position: Q4 2017 in Review

Citadel Advisors sold out of EnteroMedics Inc. (ETRM) in Q4 2017, closing a stake of 16,421 shares — an estimated $29K sold.

Citadel Advisors first reported a position in ETRM in Q3 2013 and held it in 8 quarters. The position peaked at $232K in Q1 2014. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.

Citadel Advisors reported no remaining EnteroMedics Inc. position as of Q4 2017 after selling out during the quarter.
Citadel Advisors sold 16,421 EnteroMedics Inc. shares in Q4 2017, an estimated $29K.
Citadel Advisors first reported a position in EnteroMedics Inc. in Q3 2013 and held it in 8 quarters.
Citadel Advisors's EnteroMedics Inc. position peaked at $232K in Q1 2014.
1 fund tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2017.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.